Provided by Tiger Trade Technology Pte. Ltd.

Lexicon Pharmaceuticals

1.60
-0.0550-3.33%
Volume:788.88K
Turnover:1.27M
Market Cap:675.77M
PE:-11.50
High:1.66
Open:1.66
Low:1.59
Close:1.65
52wk High:1.83
52wk Low:0.3600
Shares:423.68M
Float Shares:418.00M
Volume Ratio:2.02
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1387
EPS(LYR):-0.1387
ROE:-39.72%
ROA:-12.65%
PB:6.28
PE(LYR):-11.50

Loading ...

Lexicon posts Q4 net loss of USD 15.5 million (54.0% narrower)

Reuters
·
Mar 05

Lexicon Pharmaceuticals Q4 Operating Expenses USD 20.273 Million

THOMSON REUTERS
·
Mar 05

Lexicon Pharmaceuticals Q4 Operating Income USD -14.78 Million

THOMSON REUTERS
·
Mar 05

Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates

GlobeNewswire
·
Mar 05

Lexicon Pharmaceuticals to Join Leerink Partners Global Healthcare Conference Fireside Chat

Reuters
·
Mar 04

Lexicon Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
Mar 03

Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares

Reuters
·
Feb 27

Lexicon Pharmaceuticals Inc. to Report Fourth-Quarter 2025 Financial Results and Host Conference Call

Reuters
·
Feb 26

Insider Power Play: Major Move by Lexicon Pharmaceuticals Director Signals Growing Confidence

TIPRANKS
·
Feb 26

Insider Makes Bold Move With Fresh Lexicon Pharmaceuticals Buy

TIPRANKS
·
Feb 24

Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares

Reuters
·
Feb 23

Lexicon Pharmaceuticals Director Raymond Debbane Acquires Common Shares

Reuters
·
Feb 19

Lexicon Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Feb 18

Lexicon Pharmaceuticals Files Initial Beneficial Ownership Statement for Avicenna Life Sci Master Fund

Reuters
·
Feb 13

Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing

TIPRANKS
·
Feb 03

BUZZ-U.S. STOCKS ON THE MOVE-ResMed, Stryker, ALX Oncology

Reuters
·
Jan 30

BRIEF-Lexicon Announces Pricing Of Approximately $94.6 Million Public Offering At $1.30 Per Share

Reuters
·
Jan 30

Lexicon Pharmaceuticals Inc - Shares Offered at $1.30 per Share

THOMSON REUTERS
·
Jan 30

Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

THOMSON REUTERS
·
Jan 30

BUZZ-Lexicon Pharma slides after stock offering unveil

Reuters
·
Jan 30